Differences in blood metabolic and molecular biomarkers among normal weight, mildly obese, and moderately obese subjects

ISRCTN ISRCTN16654407
DOI https://doi.org/10.1186/ISRCTN16654407
Secondary identifying numbers N/A
Submission date
29/04/2015
Registration date
07/05/2015
Last edited
10/03/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Obesity is a term used to describe somebody who is very overweight, with a lot of body fat. It's a common problem, estimated to affect around one in every four adults and around one in every five children aged 10 to 11 in the UK. People who are obese are at risk of a number of serious and potentially life-threatening conditions, such as cardiovascular disease, particularly if the disease is diagnosed at a late stage. Biomarkers (biological markers) are molecules that come from cells which can be found circulating in a person’s blood. Scientists can use these biomarkers as a way of detecting changes in a person’s body at the very earliest stages of disease. The aim of this study is to examine biomarkers found in specific blood cells called peripheral blood mononuclear cells (PBMCs). PBMCs of obese patients will be compared with those found in healthy patients to see if there are any differences that might indicate signs of early disease. This study will also compare the genes of PBMCs to see whether they might be useful for early diagnosis and treatment of obesity-related disturbances in a person’s metabolism.

Who can participate?
Men of either healthy weight or diagnosed obese.

What does the study involve?
Participants are divided into groups according to their body mass index (BMI) calculation. All participants are asked to give a blood sample which is then tested for various biomarkers associated with health and disease.

What are the possible benefits and risks of participating?
The results of this study could potentially be used as a way to diagnose and manage obesity. Participants will be asked to provide a blood sample and may experience minor discomfort from this.

Where is the study run from?
Kyungpook National University (South Korea)

When is the study starting and how long is it expected to run for?
May 2012 to April 2013

Who is funding the study?
1. SRC Program (South Korea)
2. Fundamental Technology Program (South Korea)

Who is the main contact?
Dr UJ Jung

Contact information

Mr Un Ju Jung
Scientific

Kyungpook National University
Department of Food Science and Nutrition
1370 San-Kyuk Dong
Puk-Ku
Daegu
702-701
Korea, South

Study information

Study designCross sectional study
Primary study designObservational
Secondary study designCross sectional study
Study setting(s)Hospital
Study typeDiagnostic
Participant information sheet Not available in web format, please use contact details to request a participant information sheet.
Scientific titleDifferences in metabolic biomarkers in the blood and gene expression profiles of peripheral blood mononuclear cells among normal weight, mildly obese, and moderately obese subjects
Study objectivesThis study aims to establish metabolic and molecular differences among normal weight (BMI, 18.5~23 kg/m2), mildly obese (BMI, 25~27.5 kg/m2), and moderately obese (BMI, 27.5~30 kg/m2) Korean adult men. Levels of lipids, apolipoproteins, adipocytokines and markers of insulin resistance, oxidative stress, and liver damage in the plasma or erythrocytes will be tested alongside the gene expression profiles of peripheral blood mononuclear cells (PBMCs) using microarray analysis.
Ethics approval(s)Kyungpook National University Human Research Committee. ref: 2012-2.
Health condition(s) or problem(s) studiedBlood biomarkers of people classified as normal weight, mildly obese and moderately obese according to body mass index (BMI) calculation.
InterventionParticipants are divided into groups according to their BMI: (1) mildly obese subjects (BMI between ≥25 and <27.5 kg/m2; n = 14), (2) moderately obese subjects (BMI between ≥27.5 and <30 kg/m2; n = 12) and (3) control group normal weight range (BMI between ≥18.5 and <23 kg/m2). All participants provide blood samples for screening.
Intervention typeOther
Primary outcome measure1. Leptin, lipids (LDL- and HDL-cholesterol), apolipoprotein B levels and adiponectin
2. Circulating levels of inflammatory cytokines and markers of insulin resistance, oxidative stress, and liver damage.
Secondary outcome measures1. PBMC transcriptome data
2. Signaling pathways: oxidative phosphorylation; triglyceride synthesis; carbohydrate metabolism; insulin, mTOR, FOXO, RAP1, RAS, and TGF-β signaling; and ECM–receptor interaction.
Overall study start date01/05/2012
Completion date30/04/2013

Eligibility

Participant type(s)Mixed
Age groupAdult
Lower age limit18 Years
SexMale
Target number of participants37
Key inclusion criteria1. Participants classed as obese, having a BMI of 25~30 kg/m2 and a normal medical history
2. Healthy participants having a BMI 18.5~23 kg/m2
Key exclusion criteria1. History of cancer or cardiac, renal, hepatic, or infectious disease.
2. Current treatment with insulin
3. Current use of drugs for controlling blood glucose, blood lipids and body weight.
4. History of gastrointestinal surgery
5. Consumption of functional foods or medications that may affect the results of this study
Date of first enrolment01/06/2012
Date of final enrolment01/07/2012

Locations

Countries of recruitment

  • Korea, South

Study participating centre

Center for Food and Nutritional Genomics Research
Kyungpook National University, 1370 San-Kyuk Dong, Puk-Ku
Daegu
702-701
Korea, South

Sponsor information

Kyungpook National University
University/education

1370 San-Kyuk Dong, Puk-Ku
Daegu
702-701
Korea, South

ROR logo "ROR" https://ror.org/040c17130

Funders

Funder type

Research organisation

SRC program (grant number 2015R1A5A6001906)

No information available

Fundamental Technology Program (South Korea)

No information available

Results and Publications

Intention to publish date31/12/2016
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration.
IPD sharing plan

Editorial Notes

10/03/2016: internal review.